Inequity has been a central feature of the COVID19 pandemic. From health outcomes to access to vaccines, COVID has pushed long-standing disparities out of the shadows and into the public eye and many of these problems are global. In this episode of Coronapod we dig into a radical new collaboration of 15 countries - co-led by the WHO, and modelled on open-science. The project, called the mRNA vaccine technology transfer hub, aims to create independent vaccine hubs that could supply the global south, and take on the giants of the pharmaceutical industry in the process. But the road ahead is long - the challenges are complex and numerous, and the odds are stacked against them. But at a time when stakes couldn't be higher, momentum is building and if successful, the tantalising possibility of an end to a dangerous legacy of dependence looms. Can it be done? And if so, what needs to change to make it happen? We ask these questions and more.
This project was supported by the Pulitzer Center.
News Feature: The radical plan for vaccine equity
Never miss an episode: Subscribe to the Nature Podcast on Apple Podcasts, Google Podcasts, Spotify or your favourite podcast app. Head here for the Nature Podcast RSS feed.
Coronapod: One whistle-blower’s quest to take politics out of coronavirus surveillance
The Urgent Need to Improve Health Equity
Why a pioneering plan to distribute COVID vaccines equitably must succeed
